Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.

Journal of psychopharmacology (Oxford, England) - 1 Jul 2006

DeVane C Lindsay, Stowe Zachary N, Donovan Jennifer L, Newport D Jeffrey, Pennell Page B, Ritchie James C, Owens Michael J, Wang Jun-Sheng

Abstract excerpt

Various symptoms of mental illness occur commonly during pregnancy. It is estimated that serious mental disorders, including major depression, bipolar disorder, schizophrenia, panic and other anxiety disorders, occur with a frequency of 10 to 25% in community samples of US women in their child-be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Mental Disorders

Share to Pharmacogenetics

Share to Pregnancy

Share to Pregnancy Complications

Share to Psychotropic Drugs

Source

Identifiers

PMID: 16785271
DOI: 10.1177/1359786806066054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16785271-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.PMID 16785271Read ↗

When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populations.Semantic proximity Read ↗

Regulation of drug transporter expression and function in the placentaSemantic proximity Read ↗

An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomicsSemantic proximity Read ↗

Pharmacogenetics of drug-induced birth defects: what is known so far?Semantic proximity Read ↗

Pharmacogenomic Characterization of Childbearing-Aged Individuals With Mood Disorders in a Tertiary Care Perinatal Mental Health Clinic.Semantic proximity Read ↗

Drug Interactions at the Human Placenta: What is the Evidence?Semantic proximity Read ↗

Pharmacogenetics of Drug-Induced Birth Defects: The Role of Polymorphisms of Placental Transporter ProteinsSemantic proximity Read ↗

Gestational Age–Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted ProteomicsSemantic proximity Read ↗

Comparative modeling of fetal exposure to maternal long-acting injectable versus oral daily antipsychoticsSemantic proximity Read ↗

Mechanisms of altered hepatic drug disposition during pregnancy: small moleculesSemantic proximity Read ↗

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Semantic proximity Read ↗

Medicines in pregnancySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.